Related Experiment Videos
Persistent occultation of the vesamicol receptor
1Department of Chemistry, University of California, Santa Barbara 93106.
Neuroreport
|September 1, 1990
Summary
A novel vesamicol analog exhibits high-affinity binding to its receptor, causing a slow, temperature-dependent loss of drug binding. This discovery offers insights into acetylcholine transport inhibition mechanisms.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Vesamicol noncompetitively inhibits acetylcholine active transport into synaptic vesicles by binding to a specific receptor.
- Understanding the dynamics of drug-receptor interactions is crucial for developing effective therapeutics.
Purpose of the Study:
- To characterize a newly discovered vesamicol analog with unique binding properties.
- To investigate the kinetics and reversibility of this analog's interaction with the vesamicol receptor.
Main Methods:
- Synthesis and characterization of a vesamicol analog [(+/-)-trans-5-amino-2-hydroxy-3-(4-phenylpiperidino) tetralin].
- Time- and temperature-dependent binding assays to assess ligand interaction.
- Kinetic analysis to determine dissociation and recovery rates.
Main Results:
- The vesamicol analog demonstrated time- and temperature-dependent loss of binding with a slow recovery half-life of 5.4 hours.
- An apparent dissociation constant of 4 x 10(-11) M was calculated, indicating high-affinity binding.
- Other vesamicol analogs also showed high-affinity binding, similar to reserpine's effects on chromaffin granules.
Conclusions:
- The discovered vesamicol analog exhibits potent, slowly reversible, high-affinity binding to the acetylcholine transporter receptor.
- This interaction involves a conformational change, providing a model for understanding ligand-receptor dynamics in synaptic vesicle transport.
- Findings may inform the design of new drugs targeting cholinergic systems.